knowledge -WSS

knowledge

author：fashion 2025-10-01 23:05:27 - browse：8283

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： UnitedHealth quietly bought dozens of outpatient centers

WSS

Using force crossed my mind when examining a defiant young patient

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

CDC panel: People 65 and older should get a Covid spring booster shot

Pfizer is about to make a big push in cancer. Will investors listen?

Cholera vaccine supplies dangerously low, outbreaks surging

Change Healthcare cyberattack prompts Medicare loan program

focus

knowledge

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The problem with charging patients to message their doctors

Walensky prepares to leave CDC — and Congress — behind

Laying a path for careers in science

BioMarin wins approval for gene therapy to treat hemophilia A

Change Healthcare cyberattack prompts Medicare loan program

Duchenne breakthrough therapy leaves behind pioneering families

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

23andMe had bad news about my health. I wish a person had delivered it

Sen. Paul opposes bill to ban Chinese biotechs

knowledge

CDC advisory group OKs chikungunya vaccine

Redefining sustainability for the pharmaceutical industry

Childhood vaccination ad campaign launches in the U.K.

Change Healthcare cyberattack prompts Medicare loan program

CDC advisory group OKs chikungunya vaccine

Air quality improving but still lags in Black, Hispanic communities

focus

focus

Wikipedia

hotspot